Stories
Hospital Stocks Plunge: HSBC & Jefferies Reports Analyze Future Trends.
C
CNBC Awaaz•01-10-2026, 08:29
Hospital Stocks Plunge: HSBC & Jefferies Reports Analyze Future Trends.
- •Hospital stocks saw a sharp decline after Supreme Court remarks on drug prices and high margins.
- •HSBC states that drug price control or government intervention remains a major concern for hospital stocks, but the actual impact is unclear.
- •Jefferies maintained a 'Buy' recommendation on hospital stocks, citing strong fundamental aspects of the sector.
- •Jefferies estimates a 2-5% EBITDA impact from medicines and consumables if price controls are implemented.
- •Supreme Court questioned high MRPs on drugs and asked the center to consider a uniform 16% margin on all medicines.
Key Questions Answered
Hospital stocks plummeted following the Supreme Court's critical remarks regarding high margins and drug prices charged by hospitals.
Jefferies estimates that potential price caps on consumables and cancer drugs could result in a 2% to 5% impact on hospitals' EBITDA.
The Supreme Court scheduled the next hearing in the case concerning medicine prices and hospital margins for October 12.
